Skip to main content
padlock icon - secure page this page is secure

Synovial Fluid and Plasma Concentrations of Ceftiofur After Regional Intravenous Perfusion in the Horse

Buy Article:

$52.00 + tax (Refund Policy)


To determine radiocarpal (RC) joint synovial fluid and plasma ceftiofur concentrations after regional intravenous perfusion (RIP) and systemic intravenous (IV) administration. Study Design

Experimental cross-over study. Animals

Five normal adult horses. Methods

One RC joint was randomly selected for RIP and the contralateral RC joint was sampled to determine intrasynovial ceftiofur concentrations after IV administration. Wash-out between IV and RIP was ≥14 days. After surgical introduction of an intraarticular catheter, ceftiofur (2 g) was administered under general anesthesia either IV or by RIP after tourniquet application. Plasma and synovial fluid were collected over 24 hours. Samples were analyzed using high-performance liquid chromatography with ultraviolet detection and the results were statistically analyzed using a linear mixed effect model. Results

Mean synovial fluid ceftiofur concentrations were consistently higher after RIP than after IV administration and were > 1 g/mL (minimal inhibitory concentration [MIC] for common pathogens) for >24 hours. Mean synovial fluid peak concentration of ceftiofur after RIP and IV administration was 392.7±103.29 g/mL at 0.5 hours postinjection (HPI) and 2.72±0.31 g/mL at 1 HPI, respectively. Large variations in synovial fluid and plasma ceftiofur concentrations were observed between horses regardless of administration technique. RIP did not cause adverse effects. Conclusions

Under the present experimental conditions RIP with ceftiofur (2 g) induced significantly higher intraarticular antibiotic concentrations in the RC joint in comparison with IV administration. Moreover, after RIP, synovial fluid ceftiofur concentrations remain above the MIC for common pathogens (1 g/mL) for > 24 hours. No adverse effects from the technique or the antibiotic were observed. Clinical relevance

RIP with high doses of ceftiofur may be a beneficial adjunctive therapy when treating equine synovial infections which are caused by cephalosporin susceptible microorganisms.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: antebrachiocarpal joint; ceftiofur; horse; intraarticular administration; pharmacokinetics; synovial fluid

Document Type: Research Article

Publication date: November 1, 2005

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more